Insights

More Articles Back to Article

Genexine of S. Korea initiates coronavirus vaccine trial in humans

South Korean biotech firm Genexine is one of the companies developing a COVID-19 vaccine and has seen its company shares increase 14% last weekend on the news. The company announced it has enrolled the first of about 40 participants for its early-stage human trial to test its COVID-19 vaccine candidate. Reuters (6/19)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!